Keywords: Alchemia, Audeo Oncology, Oncology assets, De-merger plan

Alchemia oncology demerger plans

Article | 09 July 2012

Print This

Australia-based Alchemia (ASX: ACL) says it is progressing well with preparations to demerge its oncology assets, with a proposal anticipated ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in